Dr. Tanya Stoyanova’s Group Identifies a New Driver of Highly Aggressive Type of Metastatic Prostate Cancer

January 28, 2020

Tanya Stoyanova, PhD, and colleagues at the Canary Center at Stanford for Cancer Early Detection identified a new driver and regulator of highly aggressive subtype of prostate cancer, neuroendocrine prostate cancer. The work reveals new molecular mechanisms and therapeutic strategies for lethal neuroendocrine prostate cancer.